Skip to NavigationSkip to content

News

Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position this time next year.
In the latest attempt to reverse its ailing fortunes and distance itself from its polluted brand, Canadian pharma firm Valeant has announced that...
Researchers from the University of Manchester’s Centre for Dermatology Research have made a breakthrough towards the holy grail of the cosmetic...
Faron Pharmaceuticals has seen its share price plummet by more than 80% after it emerged that its drug traumakine failed to meet its primary...
Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the Basel-...
AstraZeneca and MSD’s Lynparza has been approved for use in Europe, it has emerged, with the EMA awarding authorisation to the drug as a maintenance...
The FDA has approved the use of the combination of Tafinlar and Mekinist in the treatment of BRAF V600E mutation-positive anaplastic thyroid cancer...
Johnson & Johnson has revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled...
Genmab and Janssen's combination of Darzalex with bortezomib, melphalan, and prednisone has received authorisation from the FDA for the treatment of...
AstraZeneca has confirmed it has signed a deal to jettison its schizophrenia drug Seroquel and its extended release version Seroquel XR to Chinese...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches